21 , 541551 (2011) Tehan, B
Vinu , Navarro J, Herrero-Cervera A, Garca-Cubas M, Andrs-Blasco I, Martnez-Hervs S, Real JT, Ascaso JF, Gonzlez-Navarro H: The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype
Your optimal timing is a function of your unique physiology, your daily routine, your side effect sensitivity, and your eating patterns
Ethics declarations Competing interests D.J.D
Oxidative stress also seems to be an important pathophysiological mechanism of NAFLD (190)
The benefits are comparable or superior to the benefits of GLP-1 drugs, including dramatic weight loss and secondary long-term health benefits, such as improved blood sugar levels